Oral Drug Developed at the Brigham Replicates Metabolic Benefits of Gastric Bypass

Since many patients with diabetes are ineligible for RYGB or decline it, researchers at Brigham and Women’s Hospital developed an orally administered gut barrier coating for improving glucose homeostasis.
Read More...